Monsanto Company (MON): Are There Still Some Opportunities On The Horizon

Monsanto Company (NYSE:MON) is one the of the active stocks and its unusual movement is rasing eyebrows among traders. Now trading with a market value of 54.21B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Monsanto Company (NYSE:MON) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For MON, the company currently has 3.1 billion of cash on the books, which is offset by 1.17 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 23.14 billion in total assets, balanced by 16.52 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Monsanto Company (MON) saw 874 million in free cash flow last quarter, representing a quarterly net change in cash of 1.25 billion. Perhaps most importantly where cash movements are concerned, the company saw about 1.29 billion in net operating cash flow.

Monsanto Company (NYSE:MON) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 2.66 billion in total revenues. That represents a quarterly year/year change in revenues of 0.01 in sequential terms, the MON saw sales decline by -0.01.

But what about the bottom line? After all, that’s what really matters in the end. Monsanto Company (MON) is intriguing when broken down to its core data. The cost of selling goods last quarter was 1.33 billion, yielding a gross basic income of 1.33 billion. For shareholders, given the total diluted outstanding shares of 445.3 million, this means overall earnings per share of 0.38. Note, this compares with a consensus analyst forecast of 3.39 in earnings per share for its next fiscal quarterly report.

Is Monsanto Company (NYSE:MON) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 6.45 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 19.23. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Monsanto Company.

Previous ArticleNext Article

Related Post

Companhia Energetica de Minas Gerais (CIG) Makes A... Companhia Energetica de Minas Gerais (NYSE:CIG) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trad...
Does B2Gold Corp. (BTG) Present Much Upside ? B2Gold Corp. (NYSE:BTG) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a market value of 2.95B...
For Royal Caribbean Cruises Ltd. (RCL), It May Be ... Royal Caribbean Cruises Ltd. (NYSE:RCL) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decisi...
AMC Entertainment Holdings, Inc. (AMC): How Do the... AMC Entertainment Holdings, Inc. (NYSE:AMC) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market partici...
Why Axovant Sciences Ltd. (AXON) Is Being Added to... It is interesting to note that Axovant Sciences Ltd. (NASDAQ:AXON) is active and made a solid movement in the last trading day. Now trading with a mar...